(Q34651475)

3 August 2017

title

Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy (English)

1 reference

3 August 2017

1 reference

Vincent A Pieribone

1

1 reference

3 August 2017

Julia Tsai

2

1 reference

3 August 2017

Christine Soufflet

3

1 reference

3 August 2017

Elisabeth Rey

4

1 reference

3 August 2017

Ken Shaw

5

1 reference

3 August 2017

Earl Giller

6

1 reference

3 August 2017

Olivier Dulac

7

1 reference

3 August 2017

publication date

18 July 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

48

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

1870-1874

1 reference

Neurosteroids: a new brain function?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

Effect of ganaxolone on flurothyl seizures in developing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01182.X

10.1111/J.1528-1167.2007.01182.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference